A Study of EDP-235 in Healthy Subjects

Clinical trial NCT05246878 · COMPLETED

Trial details

NCT number: NCT05246878
Sponsor: Enanta Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2022-01-28
Primary completion: 2022-07-20
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.